Article Sidebar
Received:
Mar 23, 2016Accepted:
Dec 25, 2016Published:
Dec 26, 2016DOI:
10.4314/thrb.v19i1.1Keywords:
Article Details
Jaffu O. Chilongola, Kilimanjaro Christian Medical University College & Kilimanjaro Clinical Research Institute, P.O Box 2240, Moshi
Senior Lecturer of Medical Biochemistry and ImmunologyMain Article Content
Evaluation of XpertMTB/Rif performance for diagnosis of tuberculosis among HIV positive patients in northern Tanzania
Edson W. Mollel
Jaffu O. Chilongola
Stellah G. Mpagama
Gibson S. Kibiki
Abstract
Background: Diagnosis of tuberculosis (TB) in patients co-infected with HIV poses an important challenge since they are usually smear negative for pulmonary TB. The reason for this is the low sensitivity and specificity of microscopy as the standard diagnostic method. This study aimed to evaluate the performance of the XpertMTB/Rif tool for TB diagnosis among TB-HIV co-infected patients in order to characterize TB features in HIV co-infections. The study assessed the sensitivity, specificity and positive and negative predictive values of XpertMTB/Rif for TB detection in symptomatic and asymptomatic patients.
Methods: This was a cross-sectional analytical study involving 69 patients as study participants. Demographic, clinical, laboratory and radiological data were collected. The performance of the XpertMTB/RIF and microscopy using LJ culture as a gold standard were determined and compared.
Results: XpertMTB/Rif had a higher sensitivity (100%), specificity (100%), PPV (79.2%) and NPV (98.9%) as compared to microscopy. There was a strong correlation between XpertMTB/Rif, LJ culture and Microscopy in terms of their sensitivity and specificity.
Conclusion: While using TB symptoms screening tool alone in HIV infected individuals may result into overtreatment, relying on microscopy alone has the potential of TB under-diagnosing, miss-diagnosing and delayed treatment. Our results show XpertMTB/Rif to be highly sensitive and specific to detect all culture positive TB cases among HIV patients. We recommend the adoption of XpertMTB/Rif as an early TB diagnosis tool among HIV patients for early detection of TB among HIV patients.
Donate
AJOL is a Non Profit Organisation that cannot function without donations. AJOL and the millions of African and international researchers who rely on our free services are deeply grateful for your contribution. AJOL is annually audited and was also independently assessed in 2019 by E&Y.
Your donation is guaranteed to directly contribute to Africans sharing their research output with a global readership.
- Once off donations here:
- For annual AJOL Supporter contributions, please view our Supporters page.
Tell us what you think and showcase the impact of your research!
Please take 5 minutes to contribute to our survey so that we can better understand the contribution that African research makes to global and African development challenges. Share your feedback to help us make sure that AJOL's services support and amplify the voices of researchers like you.
AJOL Stakeholder Survey
We will share a selection of stories of impact on our website for millions of users to see.
Journal Identifiers
eISSN: 1821-9241
print ISSN: 1821-6404


